Close Menu

If you've been dying to get a look at a Polonator, Keith Robison has a picture of one on his blog. Robison got a look at it at the CHI Next-Gen meeting last month and he says that "the truly intriguing angle on the Polonator is that it is a completely open architecture." He adds that is "pretty enticing from a techie angle, but it's also a pretty risky business strategy." He's also thinking about what projects he could do if he were to have a Polonator.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.